UAMS Summer Undergraduate Research Program to Increase Diversity in Research
The University of Arkansas for Medical Sciences Graduate School and Center for Diversity Affairs offer a NHLBI (National Heart, Lung, and Blood Institute) funded program entitled the UAMS Summer Undergraduate Research Program to Increase Diversity in Research. This 9 week program was designed to provide students with experiences in cardiovascular, pulmonary, or hematologic research.
To increase interest in research careers, students will be provided with:
1. research, mentoring and networking experiences
2. real-life surgical observations
3. leadership skills
4. lecture series on various research topics and responsible conduct of research training
SURP student participants will conduct a research project with a UAMS faculty mentor (list of available faculty below). Students accepted into the program will be given the opportunity to list three faculty that they would like to work with. All efforts will be made to match students with faculty that they are interested in. If those faculty are not available, the Program Directors will identify another faculty mentor. At the end of the summer, students will present their summer research and develop a 2-page paper summarizing the research project and results. They are also required to attend lectures throughout the summer. Approximately 3-5 hours of lectures will be held weekly (usually mornings on Monday, Wednesday, and Friday).
Application deadline (ALL materials must be received by this date):
February 15, 2019
Students notified of status:
Tentative Dates of program (final dates available in November 2018):
June 3 – August 2, 2019
Students will be provided a salary of $3600 for the nine week period and a per diem of $2400 is available for housing and/or travel to scientific meetings. To qualify for the program, applicants must be U.S. citizens or permanent residents and have a minimum GPA of 2.5. Applicants who are a member of an underrepresented group (African American, Hispanic American, Native American, Alaska native, Hawaiian native, or native of the US Pacific Islands), disabled, or from a disadvantaged background are encouraged to apply. Students with a background in biology or chemistry are preferred and applicants must have completed at least one year of undergraduate education. In addition, students who will complete their degree prior to the start of the program are not eligible.
1. Application. If you encounter any problems with the application, please contact Dr. Latrina Prince at firstname.lastname@example.org. The application is now closed and will reopen in November 2018. Please note that program dates are tentative and accepted students must be able to be present the entire program.
2. Unofficial copies of undergraduate transcripts. These can be uploaded with the application or sent separately.
3. Two letters of recommendation from faculty using recommendation form available online.
Please submit all materials to the name and address below. ALL application materials must be received by February 15, 2019. Incomplete applications will not be reviewed. Please contact Dr. Latrina Prince (email@example.com) to confirm receipts of materials. It is the applicant’s responsibility to make sure all application materials have been received.
If you have any questions regarding the program, please contact Dr. Latrina Prince (firstname.lastname@example.org; 501-526-7396).
|Giulia Baldini, M.D., Ph.D.||Professor||Biochemistry and Molecular Biology||Research in obesity and diabetes with focus on studying a biochemical pathway in the brain hypothalamus that regulates food intake|
|Alexei Basnakian, M.D., Ph.D.||Associate Professor||Pharmacology and Toxicology||LDL isoforms in kidney-related artherosclerosis|
|Jon Blevins, Ph.D.||Associate Professor||Microbiology and Immunology||Lyme disease|
|Karl Boehme, Ph.D.||Assistant Professor||Microbiology and Immunology||Molecular pathogenesis of mammalian reovirus|
|Marjan Boerman, Ph.D.||Associate Professor||Pharmaceutical Sciences||Cardiac radiation biology|
|Paul Gottschall, Ph.D.||Professor||Pharmacology and Toxicology||Cerebral amyloid angiopathyCNS pathology of neonatal hyposia-ischemia|
|Howard Hendrickson, Ph.D.||Associate Professor||Pharmaceutical Sciences||Metabolic and cardiovascular effects of herbal supplements.|
|Fusun Kilic, Ph.D.||Professor||Biochemistry and Molecular Biology||Blood serotonin role in hypertension-associated thrombosis|
|Julia Liu, M.D., M.Sc.||Associate Professor||Gastroenterology and Hepatology||Understanding the role of innate immune mediated cell death and barrier dysfunction in the pathogenesis of inflammatroy bowel disease|
|Paul Miller, Ph.D.||Professor||Biochemistry and Molecular Biology||Improved coagulant therapy and structure, function and evolution of cytochrome P450s|
|Shengyu Mu, Ph.D.||Assistant Professor||Pharmacology and Toxicology||Pathogenesis of salt-sensitive hypertension|
|Steven Post, Ph.D.||Professor||Pathology||Molecular and physiological basis of cardiovascular disease|
|Sung Rhee, Ph.D.||Associate Professor||Pharmacology and Toxicology||Alteration of potassium channels in cardiovascular diseases|
|Analiz Rodriguez, M.D., Ph.D.||Assistant Professor||Neurosurgery||Glioblastoma, the most common adult malignant brain tumor|
|Nancy Rusch, Ph.D.||Professor and Chair||Pharmacology and Toxicology||Vascular calcium channel expression and treatment of hypertension|
|Mark Smeltzer, Ph.D.||Professor||Microbiology and Immunology||Molecular pathogenesis of Staphylococcus aureus infections|
|Brian Storrie, Ph.D.||Professor||Physiology and Biophysics||Golgi assembly and platelet granules|
|Daniel Voth, Ph.D.||Associate Professor||Microbiology and Immunology||Coxiella burnetii a bacterial pathogen that can cause endocarditis|
|Jerry Ware, Ph.D.||Professor||Physiology and Biophysics||Circulating blood platelets and their role at the interface of thrombosis, inflammation, and cancer|
Additional Links of Interest